Aastat
Biostatistics and statistical programming services for pharmaceutical clients, delivered on a functional service provision model
Highlights
- Young companyFounded 2025
- New on EvolcAdded 2026-10-28
About Aastat
Aastat is a contract research organization (CRO) that provides biostatistical analysis and statistical programming. Services include SDTM and ADaM development and validation, TLF programming, data pooling into CDISC standards, meta-analyses, and graphing and data visualization. It also provides independent biostatistics for DSMB and DMC committees, support for FDA and EMA regulatory submissions, and SAS and data science consulting for the banking and insurance sector.
Its clients are mainly in the pharmaceutical industry and come from various countries. Work is mostly delivered under the Functional Service Provider (FSP) model, in which a dedicated professional is matched to a client's biostatistics and programming needs for the project lifecycle.
Aastat was founded in 2025 and is headquartered in Turku, Finland. It also has offices in Tampere, Finland, and in Tartu and Tallinn, Estonia. The company recruits statistical programmers and biostatisticians and accepts open applications.
Product: Outsourced biostatistics and statistical programming (SDTM/ADaM, TLF, DSMB support) delivered by dedicated professionals under the FSP model.
Jobs at Aastat
Leadership
- Jari Ahvenainen · Founder of Aastat Ltd. | Passionate Data ScientistSource: company website
More biotech & pharma companies
Afekta Technologies
Metabolomics analysis of microbial and plant compounds for food manufacturers and academic researchersNew on EvolcAmitav
Research-grade chemicals and custom synthesis for academic, pharma and biotech labs, with global shippingNew on EvolcAq Biotech
Develops phage-based biosensor diagnostics for early disease detection and monitoring from non-invasive biological samplesYoung companyNew on EvolcAranda Pharma
Develops drug candidates for people with hair loss, acne and brain diseasesNew on EvolcAurealis
Develops bacterial gene therapies for patients with chronic wounds, cancer and inflammatory diseasesNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Apache
- Elementor
- WooCommerce
- WordPress
